Page 262 - Syndipharma

Farabi Pharmaceutical Co.

Type Product Dosage form Strength Indication Status

200000IU/5ml
Penicillin V Powder for oral
Benzathine Suspension Upper respiratory tract infections, scarlet fever, IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
400000IU/5ml erysipelas, otitis media, Vincent’s angina, preven-
tion of rheumatic fever and chorea, Lyme disease,
anthrax, prophylaxis of bacterial endocarditis,
Syrup 250mg/5ml
Penicillin V and acute gingivitis
Potassium
Tablet 500mg

125mg Pharyngitis, tonsillitis, acute otitis media, acute
maxillary sinusitis, acute exacerbations of chronic
Farinat Tablet 250mg bronchitis and secondary infections of acute
(Cefuroxime axetil) bronchitis, skin and skin structure infections,
urinary tract infections, uncomplicated gonorrhea
500mg and early Lyme disease

200mg
Capsule
400mg

Cefixime 200mg Susceptible infections including gonorrhea, otitis
Tablet media, pharyngitis, tonsillitis, lower respiratory
tract infections such as bronchitis, urinary tract
Oral 400mg infections, enteric fever and shigellosis
Powder for oral 100mg/5ml
Suspension (100 ml)
Powder for oral
Farexime 100mg/5ml
Suspension (50 ml)
250mg
Capsule
500mg Bone and joint infections, otitis media, tonsillitis,
Cefalexin pharyngitis, skin and skin structure infections,
genitourinary and urinary tract infections and
125mg/ 5ml prophylaxis of bacterial endocarditis
Powder for oral
Suspension
250mg/5ml
Upper respiratory tract infections (mild to mod-
200mg erate severity), Lower respiratory tract infections
Tablet (mild to moderate severity), Skin/skin structure
infections (mild to moderate severity), Pertus-
400mg sis (whooping cough), Diphtheria, Erythrasma,
Erythromycin Intestinal amebiasis, Pelvic inflammatory disease
(PID), Conjunctivitis of newborn, pneumonia of
infancy, urogenital infections during Uncompli-
Powder for oral 200mg/5ml cated urethral, endocervical, or rectal infections
Suspension in adults, Primary syphilis, Legionnaire’s disease,
Rheumatic fever, Bacterial endocarditis, Listeria
monocytogenes infections 261